Literature DB >> 1451028

Evidence for an effector role of endothelin in closure of the ductus arteriosus at birth.

F Coceani1, L Kelsey, E Seidlitz.   

Abstract

The ductus arteriosus is a special muscular shunt that in the fetus allows blood to bypass the unexpanded lungs. It closes rapidly after birth and this event is initiated by the physiologic rise in blood oxygen tension. Endothelin-1 has been proposed by us as a local mediator for oxygen after demonstrating that it is formed within the ductus and is a potent ductus constrictor. To confirm this possibility, we have now measured the release of endothelin-1 from the isolated ductus of near-term fetal lambs at different oxygen concentrations of the medium. In addition, using the same preparation, we have examined the effect on contractile tone of compounds interfering with the synthesis (phosphoramidon, 50 microM) and action (BQ123, 1 microM) of endothelin-1. We report that release of endothelin-1 from the ductus tends to increase with the oxygen concentration up to a value mimicking the neonatal condition. Phosphoramidon and, to a greater degree, BQ123 inhibit the contraction of the vessel to oxygen. These results implicate endothelin-1 as the effector agent for oxygen in the ductus and, by extension, assign to this peptide a critical role in the closure of the vessel at birth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451028     DOI: 10.1139/y92-146

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  15 in total

1.  Redox control of oxygen sensing in the rabbit ductus arteriosus.

Authors:  H L Reeve; S Tolarova; D P Nelson; S Archer; E K Weir
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

2.  Usefulness of indomethacin for patent ductus arteriosus in full-term infants.

Authors:  Takeshi Takami; Hitoshi Yoda; Tadashi Kawakami; Hideshi Yamamura; Toshio Nakanishi; Makoto Nakazawa; Yukito Takei; Tasuku Miyajima; Akinori Hoshika
Journal:  Pediatr Cardiol       Date:  2007-01-02       Impact factor: 1.655

3.  Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel.

Authors:  M Tristani-Firouzi; H L Reeve; S Tolarova; E K Weir; S L Archer
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 4.  A mitochondrial redox oxygen sensor in the pulmonary vasculature and ductus arteriosus.

Authors:  Kimberly J Dunham-Snary; Zhigang G Hong; Ping Y Xiong; Joseph C Del Paggio; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Pflugers Arch       Date:  2015-09-23       Impact factor: 3.657

5.  Endothelin-1-endothelin receptor type A mediates closure of rat ductus arteriosus at birth.

Authors:  T Taniguchi; H Azuma; Y Okada; H Naiki; M D Hollenberg; I Muramatsu
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

6.  Does endothelin-1 reduce superior mesenteric artery blood flow velocity in preterm neonates?

Authors:  F J Weir; A Ohlsson; K Fong; K Amankwah; F Coceani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

7.  Design and serendipity in the path to prostaglandins.

Authors:  Flavio Coceani
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

8.  Responses of the post-term arterial duct to oxygen, prostaglandin E2, and the nitric oxide donor, 3-morpholinosydnonimine, in lambs and their clinical implications.

Authors:  S E Abrams; K P Walsh; S J Coker; M J Clarkson
Journal:  Br Heart J       Date:  1995-02

9.  Endothelin-induced constriction of the ductus venosus in fetal sheep: developmental aspects and possible interaction with vasodilatory prostaglandin.

Authors:  A S O Adeagbo; L Kelsey; F Coceani
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

Review 10.  Role of endothelin in uteroplacental circulation and fetal vascular function.

Authors:  Alexandra Paradis; Lubo Zhang
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.